Penobscot Investment Management Company, Inc. Bristol Myers Squibb CO Transaction History
Penobscot Investment Management Company, Inc.
- $1.08 Billion
- Q4 2024
A detailed history of Penobscot Investment Management Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 14,630 shares of BMY stock, worth $872,240. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,630
Previous 15,128
3.29%
Holding current value
$872,240
Previous $782,000
5.75%
% of portfolio
0.08%
Previous 0.07%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.46 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.72 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.67 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.6 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...